Delivery Order SPE2DB24D1006-SPE2DB25FCEZR
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,143.87 for Zepbound 10 mg/0.5 mL pen injectors on August 5, 2025, with an ultimate completion date of August 6, 2025. This non-set-aside, competitively awarded contract reflects a firm fixed price delivery order issued under AmerisourceBergen's broader pharmaceutical supply arrangement with DLA. The place of performance is listed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a $11,592.37 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors with an ultimate completion date of August 11, 2025. This is a non-set-aside, competitively awarded contract with performance based in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,048.25 for Zepbound 10 mg/0.5 mL pen injectors on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's extensive pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Zepbound 10 mg/0.5 mL pen injectors valued at $6,100.68. This firm fixed-price, non-set-aside contract is scheduled for completion by July 29, 2025, with performance at the vendor's Conshohocken, Pennsylvania location. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp serves as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $3,812.90 to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 ml pen injectors on August 5, 2025, with an ultimate completion date of August 6, 2025. This firm fixed price delivery order represents a non-competitive award issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Zepbound 15 mg/0.5 ml pen injectors with a ceiling value of $20,970.99. This is a firm fixed price delivery order with an ultimate completion date of August 20, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's capability to compete...
- The Defense Logistics Agency awarded a delivery order valued at $1,096.88 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 ml pen injections on August 14, 2025. The contract is classified as firm fixed price with an ultimate completion date of August 15, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting the company's capability to meet...
- The Defense Logistics Agency awarded a delivery order valued at $24,840.34 to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Zepbound 5 mg/0.5 ml pen injectors. This competitively awarded, firm fixed-price contract is not set aside for any specific business category and carries an ultimate completion date of August 5, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $12,539.80 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pen injectors on July 31, 2025. This firm fixed-price, competitively awarded delivery order will be fulfilled from the vendor's Conshohocken, Pennsylvania facility, with an ultimate completion date of August 1, 2025. The contract carries no set-aside designation and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply...
- The Defense Logistics Agency awarded a $1,143.87 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors. The order, which represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical, is scheduled for completion by July 22, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order was...
- SPE2DB24D1006Indefinite Delivery Contract
- SPE2DB24D1006-SPE2DB25FCEZRDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $13,187.60 on August 8, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors. This competitive, non-set-aside contract carries a firm fixed price and is scheduled for completion by August 11, 2025. The pharmaceutical products will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate office. This delivery order represents a single transaction within the company's broader relationship with the federal government as a critical supplier of pharmaceutical and medical commodities to military and veteran healthcare systems. This award is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle. AmerisourceBergen Drug Corp's federal contract portfolio demonstrates significant capability in delivering a broad spectrum of pharmaceutical products, medical supplies, and specialized healthcare commodities to support Defense Health Agency operations and other government healthcare systems. The company's track record of competitively awarded contracts across multiple therapeutic domains, ranging from specialty medications to vaccines and medical devices, underscores its established position as a prime vendor within the DLA Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.2k | 8/8/25 |